SYNDAX PHARMACEUTICALS INC FDA Approval Nov. 18, 2024, 14:30 UTC 30 0 comments FDA approve REVUMENIB Comment Full text
JUBILANT GENERICS FDA Approval Nov. 18, 2024, 09:58 UTC 24 0 comments FDA approve CITALOPRAM HYDROBROMIDE Comment Full text
HIKMA FDA Approval Nov. 18, 2024, 09:58 UTC 24 0 comments FDA approve ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE Comment Full text
TEVA PHARMS USA FDA Approval Nov. 18, 2024, 09:58 UTC 24 0 comments FDA approve LINEZOLID Comment Full text
WANBANG BIOPHARMS FDA Approval Nov. 18, 2024, 09:58 UTC 23 0 comments FDA approve CARISOPRODOL Comment Full text
CHARTWELL MOLECULAR FDA Approval Nov. 18, 2024, 09:58 UTC 18 0 comments FDA approve SULFADIAZINE Comment Full text
INGENUS PHARMS LLC FDA Approval Nov. 18, 2024, 09:58 UTC 30 0 comments FDA approve METAXALONE Comment Full text
STRIDES PHARMA FDA Approval Nov. 18, 2024, 09:58 UTC 20 0 comments FDA approve EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE Comment Full text